Conexeu Sciences is updating a prospectus covering 9,481,123 common shares with information from its Quarterly Report dated September 14, 2026. Investors using the registration materials must read the supplement alongside the underlying prospectus and attached quarterly report, which together provide the current information tied to the registered shares.
Key Highlights
- The underlying prospectus is dated May 11, 2026.
- Registration statement number 333-291845 remains associated with the prospectus materials.
- Miles Harrison signed as chief executive officer, while Stephen D. Inouye signed as chief financial officer.
Conexeu Sciences Inc. (NASDAQ: CNXU) is updating a prospectus covering 9,481,123 shares of common stock with information from its quarterly report filed September 14, 2026. The supplement attaches that report to the prospectus materials.
9,481,123 Common Shares Covered
The prospectus forms part of Conexeu Sciences’ registration statement numbered 333-291845. Its underlying prospectus carries a May 11, 2026 date. The common-stock total covered by the prospectus is 9,481,123 shares. The quarterly report supplies the information used to update the prospectus.
Prospectus Materials Must Be Read Together
The supplement is incomplete when separated from the underlying prospectus. The attached quarterly report accompanies the updated materials. Miles Harrison signed the report as chief executive officer and principal executive officer, while Stephen D. Inouye signed as chief financial officer, principal financial officer and principal accounting officer, secretary and treasurer.
FAQs
Q: What does Conexeu Sciences’ prospectus supplement cover?
A: The Conexeu Sciences prospectus supplement updates materials covering 9,481,123 common shares.
Q: When was the original Conexeu Sciences prospectus dated?
A: The underlying Conexeu Sciences prospectus was dated May 11, 2026.
Q: Did Conexeu Sciences report stock repurchases during the fiscal quarter?
A: The article does not state whether Conexeu Sciences reported stock repurchases during the fiscal quarter. It only states that a quarterly report filed September 14, 2026, was attached to update the prospectus.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.